easl studio s7e7- alcohol, cardiometabolic risks factors & sld – stigma to breakthrough therapies
Published 6 days ago • 95 plays • Length 36:46Download video MP4
Download video MP3
Similar videos
-
1:13
easl studio - s7e7 - alcohol, cardiometabolic risks factors & sld
-
7:39
easl studio policy dialogues - episode 2 - the liver, alcohol, and politics
-
34:11
easl studio s5 special episode - highlights from the easl sld summit 2023
-
38:59
easl studio s07e01 - are we relearning how to manage renal dysfunction in cirrhosis?
-
39:00
easl studio s4e8 - the central role of alcohol and food policies on liver health
-
1:11
easl studio s7e01 promo - are we relearning how to manage renal dysfunction in cirrhosis?
-
34:10
easl studio s6e1 - do we solve masld by treating obesity?
-
32:12
easl studio s6 e14 - endohepatology: the endoscopic liver gold rush
-
34:48
easl studio s6e8 - is there a role for measuring blood ammonia in patients with cirrhosis?
-
38:42
easl studio s5e9 - alcohol and the new nomenclature – a game-changer?
-
44:23
easl studio midday talks: steatotic liver disease global consensus to change nomenclature
-
1:44
s4e3 promo - a 360 approach to beat alcohol-related liver disease
-
19:53
easl congress 2024 - wrap up on metabolism, alcohol & toxicity
-
23:10
easl studio s6e7- the impact of policy measure in preventing liver diseases: the hepahealth ii study
-
1:05
easl studio - promo video - special edition – highlights from the easl sld summit 2023
-
0:16
easl studio promo
-
36:57
easl studio s7e5 - why does who engagement with steatotic liver disease matter?
-
31:45
easl studio s07e02 - what does the future management of pbc look like?
-
8:29
easl studio policy dialogues episode 3 - liver cancer: the risk of ignorance
-
45:47
easl studio s4e3 - a 360 approach to beat alcohol-related liver disease